Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nadine Azzam
Institutions:
Children's Hospital of Eastern Ontario,
CHEO Research Institute
Observed institutions:
Children's Hospital of Eastern Ontario,
CHEO Research Institute
ORCID:
0009-0008-6241-4029
Observed ORCID:
0009-0008-6241-4029
OpenAlex ID:
A5042795238
Proteomics and personalized PDX models identify treatment for a progressive malignancy within an actionable timeframe
2025
·
Georgina D Barnabas
, Tariq A Bhat
, et al.
·
EMBO Molecular Medicine
·
5
PDF
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
·
Cancer Research Communications
·
3
Tissue‐Engineered Disease Modeling of Lymphangioleiomyomatosis Exposes a Therapeutic Vulnerability to HDAC Inhibition
2023
·
Adam Pietrobon
, Julien Yockell‐Lelièvre
, et al.
·
Advanced Science
·
3
PDF
Zebrafish xenotransplantation: A versatile platform for cancer and stem cell translational research
2022
·
Nicole Melong
, Kim Kobar
, et al.
·
Elsevier eBooks
·
3
Abstract B007: High-risk pediatric cancer models in zebrafish, mouse and short-term culture predict individual patient responses to therapy
2024
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
·
Cancer Research
·
1
Abstract 4670: True bench-to-bedside science: An international pilot study modeling hard-to-cure pediatric cancers to prioritize therapeutic intervention
2023
·
Nadine Azzam
, Nicole Melong
, et al.
·
Cancer Research
·
1
Data from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
Figure S1 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
Figure 3 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
Figure S3 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
Figure 4 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
Figure S4 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
Figure S2 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
Table S1 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
PDF
Table 2 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
Table 1 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
Table S2 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
Figure 2 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
Figure 5 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
Abstract 937: Prioritizing treatment targets for an adolescent with metastatic processive malignancy using proteomics and personalized xenograft models within an actionable timeframe
2024
·
Georgina D. Barnabas
, Tariq A. Bhat
, et al.
·
Cancer Research
Show more works
View as search
Works count:
21
Citation count:
16
H-index:
3
I10-index:
Year
Topic
Type